RECRUITING

Healthy Eating and Active Lifestyle (HEAL): Breast Cancer Program Outcomes

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this single-group prospective study is to examine the impact of the Healthy Eating and Active Lifestyle (HEAL) Breast Cancer program on participants' perceived stress, biometrics, basic labs, lifestyle behaviors, self-efficacy, mental health, and quality of life. Participants will participate in an 8-week program of 90-minute virtual sessions each week to decrease risk of cancer recurrence. Program participants can choose to participate in the research study which will include data collection (surveys, biometrics, basic labs). The data collection will occur at four timepoints - baseline prior to program start, post-program, 3 month follow-up, and 6 month follow-up.

Official Title

A Prospective Study of the Healthy Eating and Active Lifestyle (HEAL): Breast Cancer Program on Survivorship Outcomes

Quick Facts

Study Start:2023-09-21
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06078761

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Adult ≥ 18 years old
  2. 2. Diagnosis of breast cancer
  3. 3. Enrolled in the HEAL: Breast Cancer Program
  4. 4. Able to speak, read, and understand English fluently
  5. 5. Willing and able to provide informed consent
  6. 6. Willing and able to comply with all study procedures and requirements for the duration of the study
  1. 1. Not willing or able to provide informed consent
  2. 2. Not willing or able to comply with all study procedures and requirements for the duration of the study

Contacts and Locations

Study Contact

Amanda T. Sawyer, PhD
CONTACT
407-200-2901
amanda.sawyer@adventhealth.com
Tere Richard, MHSA
CONTACT
407-200-2901
tere.richard@adventhealth.com

Principal Investigator

Amanda T. Sawyer, PhD
PRINCIPAL_INVESTIGATOR
AdventHealth

Study Locations (Sites)

AdventHealth
Orlando, Florida, 32804
United States

Collaborators and Investigators

Sponsor: AdventHealth

  • Amanda T. Sawyer, PhD, PRINCIPAL_INVESTIGATOR, AdventHealth

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-21
Study Completion Date2024-12

Study Record Updates

Study Start Date2023-09-21
Study Completion Date2024-12

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer